A memorandum of understanding (MoU) between AD Ports Group and UAE-based Hayat Biotech would allow the latter to establish manufacturing facilities all over the world and offer logistical services to serve its global customers.
The agreement covers the shipping of strategic construction supplies, including containers, machinery, raw materials and equipment, to support the construction of Hayat Biotech’s global biopharmaceutical manufacturing facilities.
The facilities – once complete – will produce a number of vital biopharmaceutical products, including the Hayat-Vax vaccine, the first indigenously produced Covid-19 vaccine in the UAE and Arab world.
As part of the collaboration, the distribution will be handled by the HOPE Consortium, which is said to operate one of the largest and most complete end-to-end pharma supply chains today.
Alongside the Department of Health – Abu Dhabi, Etihad Cargo, Maqta Gateway, Rafed, and SkyCell, AD Ports Group is one of the founding members of the HOPE Consortium, which is helping lead the distribution of Covid-19 vaccines to all parts of the globe. The partnership has handled over 250 million vaccine doses across 60 countries.
Captain Mohamed Juma Al Shamisi, MD and group CEO of AD Ports Group, and chairman of the HOPE Consortium’s Executive Committee, said: “As a nation, the UAE continues to take significant steps towards enabling global access to pharmaceutical products and supplies. Thanks to our partnership with Hayat Biotech, we are cementing the pivotal role that AD Ports Group and the HOPE Consortium are playing in supporting our healthcare industry’s efforts to serve communities and markets all around the world.
Robert Sutton, CEO of Logistics Cluster, AD Ports Group, said: “We are pleased to leverage our complete end-to-end logistics solutions, which cover everything from transportation and storage, to monitoring and delivery of pharma supplies, anywhere around the world. Capitalising on Abu Dhabi’s strategic position as a global gateway, we are working together to help position the emirate as a leading global logistics hub for the life sciences sector.”
Naser Al Yammahi, deputy CEO, Hayat Biotech, said: “The world is facing fundamental challenges that are affecting our wellbeing, health, and quality of life; therefore, we made it our responsibility to deliver innovative biotechnological capabilities around the globe. Thanks to the partnership with AD Ports Group, we are looking to further expand our distribution network to deliver necessary biopharmaceutical products to improve the health of our nation and across the globe.”
In recent news, AD Ports Group and Uzbekistan’s oil and gas company, Sanoat Energetika Guruhi (SEG), signed an agreement to establish a joint venture for developing logistics infrastructure and services in Uzbekistan.
